DK160129C - Farmaceutisk praeparat indeholdende en gangliosidforbindelse, et indre ester-gangliosidderivat eller blandinger deraf - Google Patents

Farmaceutisk praeparat indeholdende en gangliosidforbindelse, et indre ester-gangliosidderivat eller blandinger deraf

Info

Publication number
DK160129C
DK160129C DK505584A DK505584A DK160129C DK 160129 C DK160129 C DK 160129C DK 505584 A DK505584 A DK 505584A DK 505584 A DK505584 A DK 505584A DK 160129 C DK160129 C DK 160129C
Authority
DK
Denmark
Prior art keywords
ganglioside
mixtures
pharmaceutical preparation
preparation containing
compound
Prior art date
Application number
DK505584A
Other languages
English (en)
Other versions
DK160129B (da
DK505584A (da
DK505584D0 (da
Inventor
Francesco Della Valle
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of DK505584D0 publication Critical patent/DK505584D0/da
Publication of DK505584A publication Critical patent/DK505584A/da
Publication of DK160129B publication Critical patent/DK160129B/da
Application granted granted Critical
Publication of DK160129C publication Critical patent/DK160129C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Otolaryngology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK505584A 1983-11-08 1984-10-23 Farmaceutisk praeparat indeholdende en gangliosidforbindelse, et indre ester-gangliosidderivat eller blandinger deraf DK160129C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8349288A IT1212896B (it) 1983-11-08 1983-11-08 Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
IT4928883 1983-11-08

Publications (4)

Publication Number Publication Date
DK505584D0 DK505584D0 (da) 1984-10-23
DK505584A DK505584A (da) 1985-05-09
DK160129B DK160129B (da) 1991-02-04
DK160129C true DK160129C (da) 1991-07-01

Family

ID=11270228

Family Applications (1)

Application Number Title Priority Date Filing Date
DK505584A DK160129C (da) 1983-11-08 1984-10-23 Farmaceutisk praeparat indeholdende en gangliosidforbindelse, et indre ester-gangliosidderivat eller blandinger deraf

Country Status (22)

Country Link
US (1) US4639437A (da)
EP (1) EP0145209B1 (da)
JP (1) JPS60132920A (da)
KR (1) KR850003503A (da)
AT (1) ATE47035T1 (da)
AU (1) AU569920B2 (da)
BE (1) BE900994A (da)
CH (1) CH662278A5 (da)
DE (1) DE3480053D1 (da)
DK (1) DK160129C (da)
ES (1) ES8608532A1 (da)
FR (1) FR2554346B1 (da)
GR (1) GR80853B (da)
IL (1) IL73292A (da)
IN (1) IN163563B (da)
IT (1) IT1212896B (da)
LU (1) LU85633A1 (da)
MX (1) MX163574B (da)
NO (1) NO844443L (da)
NZ (1) NZ209974A (da)
PT (1) PT79466B (da)
ZA (1) ZA848541B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
JPS6368526A (ja) * 1986-09-11 1988-03-28 Mect Corp シアリルグリセライドからなる神経障害疾患治療剤
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
US6407061B1 (en) * 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
AU6909091A (en) * 1989-12-05 1991-06-26 Ramsey Foundation Neurologic agents for nasal administration to the brain
IT1249034B (it) * 1990-06-29 1995-02-11 Fidia Spa Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
WO1992017189A1 (en) * 1991-03-29 1992-10-15 The Regents Of The University Of California Gangliosides with immunosuppressive activity
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5567684A (en) * 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
US7273618B2 (en) * 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
AU2002326805B2 (en) 2001-08-29 2009-01-22 Seneb Biosciences, Inc. Novel synthetic ganglioside derivatives and compositions thereof
AU2004220087A1 (en) 2003-03-06 2004-09-23 Seneb Biosciences, Inc. Methods and compositions for the enzymatic synthesis of gangliosides
CU23317A1 (es) 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
EP2410846B1 (en) 2009-03-25 2016-09-07 Seneb Biosciences, Inc. Glycolipids as treatment for disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL262354A (da) * 1960-03-17
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
US4094968A (en) * 1972-09-06 1978-06-13 Burroughs Wellcome Co. Treatment for allergy and method of composition thereof
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions

Also Published As

Publication number Publication date
ATE47035T1 (de) 1989-10-15
KR850003503A (ko) 1985-06-20
FR2554346B1 (fr) 1987-11-20
IN163563B (da) 1988-10-08
ES537300A0 (es) 1986-07-16
DK160129B (da) 1991-02-04
JPS60132920A (ja) 1985-07-16
ES8608532A1 (es) 1986-07-16
CH662278A5 (fr) 1987-09-30
AU569920B2 (en) 1988-02-25
ZA848541B (en) 1985-06-26
IT8349288A0 (it) 1983-11-08
PT79466B (en) 1986-12-12
IT1212896B (it) 1989-11-30
DK505584A (da) 1985-05-09
EP0145209B1 (en) 1989-10-11
MX163574B (es) 1992-06-02
PT79466A (en) 1984-12-01
EP0145209A3 (en) 1986-11-26
AU3518984A (en) 1985-05-16
DE3480053D1 (en) 1989-11-16
BE900994A (nl) 1985-05-07
IL73292A (en) 1988-07-31
EP0145209A2 (en) 1985-06-19
JPH0211570B2 (da) 1990-03-14
US4639437A (en) 1987-01-27
FR2554346A1 (fr) 1985-05-10
NO844443L (no) 1985-05-09
LU85633A1 (fr) 1985-06-04
DK505584D0 (da) 1984-10-23
GR80853B (en) 1985-02-26
IL73292A0 (en) 1985-01-31
NZ209974A (en) 1987-02-20

Similar Documents

Publication Publication Date Title
DK160129C (da) Farmaceutisk praeparat indeholdende en gangliosidforbindelse, et indre ester-gangliosidderivat eller blandinger deraf
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
NO173726C (no) Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
IT8148129A0 (it) Dispositivo per la somministrazione di gas anestetico
FR2362833A1 (fr) Nouveaux derives 5 de prostaglandine, leur procede de preparation et medicament les contenant
SE8500996D0 (sv) Method of treatment
DK619484D0 (da) Farmaceutisk praeparat mod rheumatiske lidelser
FI884960A0 (fi) Anvaendning av 2-pyrimidinyl-1-piperazin-derivat.
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
PT97052A (pt) Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
JPS5215813A (en) Preparation of stable medicine including homopyrimidazole derivative for aural administration
IT8322949A0 (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
IT1228135B (it) Composizione farmaceutica sterile per la somministrazione per via iniettabile della citidindifosfocolina veicolata tramite i liposomi
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
NO156898C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte acylderivater av oktahydro-1h-indol-2-karboksylsyre.
IT8820387A0 (it) Composizioni farmaceutiche comprendenti derivati delglicerolo_3_fosfato atte al trattamento di patologie del sistema nervoso.

Legal Events

Date Code Title Description
PBP Patent lapsed